MockV Solutions Announces Phase 1 SBIR Grant Award from the National Center for Advancing Translations Sciences
Rockville, MD – Dec. 7th, 2017 – MockV Solutions, Inc. (MockV or the Company), a biotechnology company developing non-infectious viral clearance prediction products that address the unmet needs of process development scientists as they establish biopharmaceutical manufacturing platforms, announc